Disclosure Of First-Time Adoption [Text Block]

Cinclus Pharma Holding AB - Filing #5879291

Concept	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	As at 2024-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31
Disclosure of first-time adoption [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity	—	771 997 SEK	—	920,000 SEK	28 667 SEK	—	—	—	1 297 740 SEK	555 330 SEK	—	76 800 SEK	606 837 SEK	—	—	—	509,000 SEK	26 004 SEK	—	503 524 SEK	126 874 SEK	394 163 SEK	509,000 SEK	16 837 SEK	503 691 SEK
Comprehensive income	– SEK	—	2 664 SEK	—	—	168 031 SEK	165 367 SEK	– SEK	—	—	205 951 SEK	—	—	215 118 SEK	9 167 SEK	– SEK	—	—	– SEK	—	—	—	—	—	—
Profit (loss)	– SEK	—	– SEK	—	—	168 031 SEK	168 031 SEK	– SEK	—	—	215 118 SEK	—	—	215 118 SEK	– SEK	– SEK	—	—	– SEK	—	—	—	—	—	—